Methods to Manage Intra-operative Floppy-iris Syndrome and Poor Pupil Dilation in Cataract Surgery (IFIS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Cataract surgery is one of the most frequently performed surgeries worldwide and complications are rare. However, there are factors that increase the risk of complications, such as poor pupil dilation and intra-operative floppy iris syndrome (IFIS). Reasons for a small pupil size are pseudoexfoliation syndrome (PXF) syndrome, uveitis or synechia and the use of pilocarpin drops. IFIS is a syndrome usually caused by systemic alpha1-blockers (foremost tamsulosin) used to treat benign prostatic hyperplasia.1,2 As described by Chang and Campbell3 IFIS is characterized by billowing of a flaccid iris stroma, a propensity for iris prolapse towards the phacoemulsification tip as well as towards the incisions and progressive intra-operative pupil constriction.
Stopping tamsulosin pre-operatively did not show to effectively prevent IFIS.4,5 However, it is of high importance to identify patients prior to surgery, who are treated with alpha1-blockers, or patients with a small pupil size and poor pharmacological pupil dilation. Some methods, such as intracameral injection of phenylephrine is only sufficient in a few cases 6, and a disadvantage is the risk of a hypertensive episode.7 Another pharmacological method is the use of atropine drops pre-operatively, but this method did not show to sufficiently reduce IFIS.4
Different methods were shown to reduce intra-operative problems due to IFIS/small pupil size:
The use of highly cohesive ophthalmic viscosurgical devices (OVD), also called viscoadaptives, such as sodium hyaluronate (e.g. AMO Healon5 or Croma Eyefill H.D.) help to viscodilate the pupil and by resting on the iris during the entire phacoemulsification procedure reduce the risk of iris prolapsing towards the incisions. This method is more dependent on a central phacoemulsification technique and low fluidic parameters to allow the OVD to stay on the iris during the entire procedure.8 In case of a small pupil, pupil stretching with 2 instruments can be used additively.
Another option to stabilize the pupil size is the use of mechanical pupil expansion devices, such as
- Iris retractors - these devices are routinely used to dilate the pupil intra-operatively. Typically, 4 or 5 iris retractors, also called iris hooks, are inserted through 4-5 incisions. Usually, the IFIS pupil is very elastic and the risk of overstretching is small.8
- Pupil expansion rings, such as the Malyugin ring. This ring is placed on the pupil margin with an injector through the main incision. It eliminates the need of additional incisions and saves time.9
Rationale To compare different methods to manage IFIS and poor pupil dilation in cataract surgery: a pupil expansion ring (Malyugin Ring), iris retractors (iris hooks) and a viscoadaptive OVD.
| Condition | Intervention |
|---|---|
|
Management of Intraoperative Floppy-iris Syndrome and Small Pupils With Different Mechanical Devices |
Device: Malyugin Ring Device: Iris hooks Device: standard OVD Device: OVD |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Methods to Manage Intra-operative Floppy-iris Syndrome and Poor Pupil Dilation in Cataract Surgery: an Exploratory Study |
- Mean difference in flare (pre-operatively to 1 day post-operatively) between the OVD and the device group [ Time Frame: pre-operatively to 1 day postoperatively ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 80 |
| Study Start Date: | February 2012 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: standard OVD |
Device: standard OVD
use of a standard cohesive OVD during cataract surgery
|
| Active Comparator: Iris hooks |
Device: Iris hooks
insertion of iris retractors to stabilize the pupil during cataract surgery
|
| Active Comparator: Malyugin Ring |
Device: Malyugin Ring
insertion of a Malyugin Ring to stabilite the pupil during cataract surgery
|
| Active Comparator: OVD |
Device: OVD
use of a highly cohesive OVD during cataract surgery
|
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age-related cataract
- Age 21 and older
- written informed consent prior to surgery
- Small pupil group: Patients with a pupil size below 4.0 mm after pharmacological dilation with tropicamide 1% and phenylephrine 2.5% gtt as used routinely for pupil dilation,
- IFIS group: Patients, who currently are or have been treated with Alpha-adrenergic receptor antagonists (Tamsulosin- i.e. Alna ret.®)
Exclusion Criteria:
- Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
- Traumatic cataract
- History of uveitis
- Any ophthalmic pathology that could compromise the measurements
Contacts and Locations| Contact: Oliver Findl, MD, MBA | +43 1 91021 ext 84611 | oliver@findl.at |
| Austria | |
| VIROS- Vienna Institute for Research in Ocular Surgery - Department of Ophthalmology, Hanusch Hospital Vienna | Recruiting |
| Vienna, Austria, 1140 | |
| Contact: Oliver Findl, MD; MBA +43 1 91021 84611 oliver@findl.at | |
| Sub-Investigator: Nino Hirnschall, MD | |
| Sub-Investigator: Sophie Tatzreiter, MD | |
| Sub-Investigator: Maria Weber, MD | |
| Principal Investigator: | Oliver Findl, MD, MBA | VIROS- Vienna Institute for Research in Ocular Surgery |
More Information
No publications provided
| Responsible Party: | Prim. Prof. Dr. Oliver Findl, MBA, Prim. Univ.-Prof. Oliver Findl, MD, MBA, Vienna Institute for Research in Ocular Surgery |
| ClinicalTrials.gov Identifier: | NCT01778959 History of Changes |
| Other Study ID Numbers: | IFIS |
| Study First Received: | January 25, 2013 |
| Last Updated: | January 25, 2013 |
| Health Authority: | Austria: Federal Ministry for Health Family and Youth |
Additional relevant MeSH terms:
|
Miosis Mydriasis Cataract Pupil Disorders Neurologic Manifestations |
Nervous System Diseases Eye Diseases Signs and Symptoms Lens Diseases |
ClinicalTrials.gov processed this record on May 19, 2013